HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMID 19424050)

Published in AIDS on June 01, 2009

Authors

Hugues Fausther-Bovendo1, Nathalie Sol-Foulon, Daniel Candotti, Henri Agut, Olivier Schwartz, Patrice Debré, Vincent Vieillard

Author Affiliations

1: INSERM UMR945, Hôpital Pitié-Salpêtrière, Paris, France.

Articles citing this

Viral quasispecies evolution. Microbiol Mol Biol Rev (2012) 2.69

Innate immunity against HIV: a priority target for HIV prevention research. Retrovirology (2010) 1.41

Innate immune activation in primary HIV-1 infection. J Infect Dis (2010) 1.40

The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR. J Virol (2012) 1.35

Human NK cell repertoire diversity reflects immune experience and correlates with viral susceptibility. Sci Transl Med (2015) 1.12

HIV gp41 engages gC1qR on CD4+ T cells to induce the expression of an NK ligand through the PIP3/H2O2 pathway. PLoS Pathog (2010) 1.07

HIV-1 Nef and Vpu are functionally redundant broad-spectrum modulators of cell surface receptors, including tetraspanins. J Virol (2014) 0.99

Evasion from NK cell-mediated immune responses by HIV-1. Microbes Infect (2012) 0.99

Innate immunity in acute HIV-1 infection. Curr Opin HIV AIDS (2011) 0.95

Quantification of the relative importance of CTL, B cell, NK cell, and target cell limitation in the control of primary SIV-infection. PLoS Comput Biol (2011) 0.92

Analysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohort. Oncoimmunology (2013) 0.92

Kaposi's sarcoma-associated herpesvirus ORF54/dUTPase downregulates a ligand for the NK activating receptor NKp44. J Virol (2012) 0.87

The modulation of the cell-cycle: a sentinel to alert the NK cells of dangers. Front Immunol (2013) 0.86

Structural insights into activation of antiviral NK cell responses. Immunol Rev (2012) 0.85

Novel interaction between proliferating cell nuclear antigen and HLA I on the surface of tumor cells inhibits NK cell function through NKp44. PLoS One (2013) 0.84

Lysis of HIV-1-infected autologous CD4+ primary T cells by interferon-alpha-activated NK cells requires NKp46 and NKG2D. AIDS (2015) 0.83

NKp44 and Natural Cytotoxicity Receptors as Damage-Associated Molecular Pattern Recognition Receptors. Front Immunol (2015) 0.82

Modest attenuation of HIV-1 Vpu alleles derived from elite controller plasma. PLoS One (2015) 0.81

HIV-1 Vpu mediated downregulation of CD155 requires alanine residues 10, 14 and 18 of the transmembrane domain. Virology (2014) 0.81

Comparative analysis of NK-cell receptor expression and function across primate species: Perspective on antiviral defenses. Self Nonself (2010) 0.79

Viral protein R upregulates expression of ULBP2 on uninfected bystander cells during HIV-1 infection of primary CD4+ T lymphocytes. Virology (2013) 0.78

The role of NK cells in HIV-1 protection: autologous, allogeneic or both? AIDS Res Ther (2016) 0.77

Remodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and Persistence. Viruses (2016) 0.77

Viral Evasion of Natural Killer Cell Activation. Viruses (2016) 0.77

Insufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cells. Retrovirology (2016) 0.75

Perspectives for immunotherapy: which applications might achieve an HIV functional cure? Oncotarget (2016) 0.75

Inflammatory colonic innate lymphoid cells are increased during untreated hiv-1 infection and associated with markers of gut dysbiosis and mucosal immune activation. J Acquir Immune Defic Syndr (2017) 0.75

Articles by these authors

SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature (2011) 9.30

Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J Exp Med (2007) 5.58

The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood (2007) 4.14

Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation (2003) 3.55

APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. Nature (2005) 3.53

CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest (2007) 3.39

DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J Exp Med (2003) 3.32

Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep (2003) 3.29

Inefficient human immunodeficiency virus replication in mobile lymphocytes. J Virol (2006) 3.26

Characterization of reemerging chikungunya virus. PLoS Pathog (2007) 3.22

Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Transfusion (2005) 3.08

SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells. Retrovirology (2012) 2.92

HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation. Immunity (2004) 2.86

DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J Biol Chem (2003) 2.82

Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol (2010) 2.64

Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses. Immunity (2010) 2.52

Human muscle satellite cells as targets of Chikungunya virus infection. PLoS One (2007) 2.47

Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication. Nat Immunol (2007) 2.43

Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity (2007) 2.42

The immune paradox of sarcoidosis and regulatory T cells. J Exp Med (2006) 2.35

Simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapses. J Virol (2009) 2.33

Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation. Am J Respir Crit Care Med (2007) 2.27

Innate sensing of HIV-infected cells. PLoS Pathog (2011) 2.22

Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 study. PLoS One (2008) 2.14

Combination of HIV-1-specific CD4 Th1 cell responses and IgG2 antibodies is the best predictor for persistence of long-term nonprogression. J Infect Dis (2005) 2.03

The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host Microbe (2012) 2.03

Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol (2005) 2.00

Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis (2008) 1.93

Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes. J Virol (2005) 1.92

Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma. Cancer Res (2011) 1.91

Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse. Immunity (2006) 1.90

DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation. Blood (2003) 1.89

Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. J Exp Med (2010) 1.86

HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice. Proc Natl Acad Sci U S A (2013) 1.85

Evidence of premature immune aging in patients thymectomized during early childhood. J Clin Invest (2009) 1.81

Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity. PLoS Pathog (2011) 1.81

CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur J Immunol (2011) 1.81

NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect. Blood (2005) 1.78

Tetherin restricts productive HIV-1 cell-to-cell transmission. PLoS Pathog (2010) 1.73

Nucleic acid testing to detect HBV infection in blood donors. N Engl J Med (2011) 1.69

From RNA to quasispecies: a DNA polymerase with proofreading activity is highly recommended for accurate assessment of viral diversity. J Virol Methods (2003) 1.69

ZAP-70 kinase regulates HIV cell-to-cell spread and virological synapse formation. EMBO J (2007) 1.68

NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand. Proc Natl Acad Sci U S A (2005) 1.67

The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood (2002) 1.66

Human NK cells display major phenotypic and functional changes over the life span. Aging Cell (2010) 1.65

HIV-1 Nef-induced upregulation of DC-SIGN in dendritic cells promotes lymphocyte clustering and viral spread. Immunity (2002) 1.62

Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease. Arthritis Rheum (2011) 1.59

NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs. PLoS One (2010) 1.59

Dendritic cells and HIV-specific CD4+ T cells: HIV antigen presentation, T-cell activation, and viral transfer. Blood (2006) 1.58

Modulation of the immunological synapse: a key to HIV-1 pathogenesis? Nat Rev Immunol (2007) 1.57

High cytotoxic and specific migratory potencies of senescent CD8+ CD57+ cells in HIV-infected and uninfected individuals. J Immunol (2006) 1.55

Dual inhibitory effects of APOBEC family proteins on retrotransposition of mammalian endogenous retroviruses. Nucleic Acids Res (2006) 1.53

Restriction of foamy viruses by APOBEC cytidine deaminases. J Virol (2006) 1.52

Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol (2011) 1.50

Identification of cryptic MHC I-restricted epitopes encoded by HIV-1 alternative reading frames. J Exp Med (2004) 1.48

HIV-1 buds and accumulates in "nonacidic" endosomes of macrophages. Cell Host Microbe (2007) 1.47

Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection. Am J Respir Crit Care Med (2014) 1.45

Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity. AIDS (2006) 1.43

Infectivity of blood products from donors with occult hepatitis B virus infection. Transfusion (2013) 1.43

A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells. Immunity (2013) 1.41

Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV. AIDS (2005) 1.40

B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease. J Clin Immunol (2010) 1.39

Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood (2005) 1.39

Functional characterization of HIV-1 Nef mutants in the context of viral infection. Virology (2006) 1.36

Chikungunya virus-induced autophagy delays caspase-dependent cell death. J Exp Med (2012) 1.34

Classification of HHV-6A and HHV-6B as distinct viruses. Arch Virol (2013) 1.33

Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J Hepatol (2008) 1.30

DC-SIGN induction in alveolar macrophages defines privileged target host cells for mycobacteria in patients with tuberculosis. PLoS Med (2005) 1.30

Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission. J Exp Med (2013) 1.28

Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes. J Gen Virol (2007) 1.28

HIV-1 Nef inhibits ruffles, induces filopodia, and modulates migration of infected lymphocytes. J Virol (2009) 1.28

Automated genome-wide visual profiling of cellular proteins involved in HIV infection. J Biomol Screen (2011) 1.26

Identification of a cellular ligand for the natural cytotoxicity receptor NKp44. Blood (2013) 1.25

CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation. J Immunol (2011) 1.24

Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection. Hepatology (2010) 1.23

Partial inhibition of human immunodeficiency virus replication by type I interferons: impact of cell-to-cell viral transfer. J Virol (2009) 1.21

Polymorphism in the microglial cell-mobilizing CX3CR1 gene is associated with survival in patients with glioblastoma. J Clin Oncol (2008) 1.21

Differential distribution and internal translation efficiency of hepatitis C virus quasispecies present in dendritic and liver cells. Blood (2002) 1.19

SAMHD1 restricts HIV-1 cell-to-cell transmission and limits immune detection in monocyte-derived dendritic cells. J Virol (2012) 1.18

A novel pathway down-modulating T cell activation involves HPK-1-dependent recruitment of 14-3-3 proteins on SLP-76. J Exp Med (2007) 1.17

Deciphering the molecular bases of Mycobacterium tuberculosis binding to the lectin DC-SIGN reveals an underestimated complexity. Biochem J (2005) 1.16

Chronic lymphocytic leukaemia cells are efficiently killed by an anti-CD20 monoclonal antibody selected for improved engagement of FcgammaRIIIA/CD16. Br J Haematol (2008) 1.16

Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases. J Gen Virol (2005) 1.16